Primary Hepatic Follicular Lymphoma : A Case Report and Discussion of Chemotherapy and Favorable Outcomes

スポンサーリンク

概要

• 論文の詳細を見る

• This report concerns a rare case of follicular lymphoma with features suggestive of primary hepatic lymphoma. At the disease onset, multiple nodular lesions in the liver and small para-aortic nodes were detected by abdominal magnetic resonance imaging without generalized lymphadenopathy. After careful observation for three months, lymphadenopathy was observed in the right occipital, para-aortic, and bilateral inguinal regions. The patient was treated with R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone) and achieved complete remission for more than 2 years. To the best of our knowledge, this is the ninth report of primary hepatic follicular lymphoma. Insufficient cases have been reported to determine the long-term outcome and clinical characteristics of primary hepatic follicular lymphoma. However, it seems that patients with primary hepatic follicular lymphoma that are treated with appropriate chemotherapy with or without surgical resection have favorable outcomes. [J Clin Exp Hematopathol 47(2) : 73-77, 2007]

• 日本リンパ網内系学会の論文
• 2007-11-01

著者

• Kamiya Yoshikazu

  Department of Hematology, Meitetsu Hospital

• Kato Harumi

  Department of Cardiology, Kurashiki Central Hospital

• 三木 義男

  癌研ゲノムセンター

• OGURA Michinori

  Department of Hematology and Cell Therapy, Aichi Cancer Center

• MORISHIMA Yasuo

  Department of Hematology and Cell Therapy, Aichi Cancer Center

• KAGAMI Yoshitoyo

  Department of Hematology and Cell Therapy, Aichi Cancer Center

• TAJI Hirofumi

  Department of Hematology and Cell Therapy, Aichi Cancer Center

• Tobinai K

  Hematology And Stem Cell Transplantation Divisions National Cancer Center Hospital

• NAKAMURA Shigeo

  Department of Clinical Pathology, Aichi Cancer Center Hospital

• Moriwaki Yuji

  長崎大学大学院医歯薬学総合研究科附属原爆後障害医療研究施設 分子治療研究分野

• Nakamura Shigeo

  群馬県立がんセンター 病理検査

• Kishimoto Yuji

  The First Department Of Internal Medicine Kansai Medical University

• Kagami Y

  Department Of Hematology Japanese Red Cross Nagoya First Hospital

• Tanimoto Kazuki

  国立がんセンター中央病院

• Kagami Yoshitoyo

  名古屋大学医学部附属病院 病理部

• OGITA Masami

  Sapporo National Hospital

• Yamamoto Kazuhito

  Department Of Hematology And Cell Therapy Aichi Cancer Center Hospital

• Yamamoto Kazuhito

  愛知県がんセンター中央病院 血液･細胞療法部

• Kanakura Yuzuru

  大阪大学 医学系研究科心臓血管外科

• Kamiya Yoshikazu

  Department Of Hematology Meitetsu Hospital

• Matsumoto-mishima Yuko

  癌研究会癌化学療法センター 臨床研究部

• Kawase Yoshiaki

  Department Of Internal Medicine Japanese Red Cross Nagoya First Hospital

• Matsuno Yoshihiro

  Department Of Chemotherapy Tokyo Metropolitan Cancer And Infectious Diseases Center Komagome Hospita

• OSHIRO Aya

  Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital

• GOMYO Hiroshi

  Department of Hematology and Cell Therapy, Aichi Cancer Center

• KAWASE Takakazu

  Department of Hematology and Cell Therapy, Aichi Cancer Center

• OHSHIRO Aya

  Department of Hematology and Cell Therapy, Aichi Cancer Center

• OYAMA Takashi

  Department of Medical Oncology, Aichi Cancer Center

• Nakamura S

  Department Of Pathology And Clinical Laboratories Nagoya University Hospital

• Nakamura Shigeo

  Department Of Pathology Nagoya University School Of Medicine

• Taji Hirohumi

  Department Of Hematology And Cell Therapy Aichi Cancer Center

• Gomyo Hiroshi

  Department Of Hematology And Cell Therapy Aichi Cancer Center

• Nakamura Shigeo

  Department Of Pathology Nagoya University Graduate School Of Medicine

• Hara Kazuo

  Department Of Hematology And Cell Therapy Aichi Cancer Center Hospital

• Morishima Yasuo

  Department Of Hematology And Chemotherapy

• Takatsuki K

  Kumamoto Univ. School Of Medicine Kumamoto Jpn

• Ogura M

  Department Of Hematology And Cell Therapy Aichi Cancer Center

• Kawase Takakazu

  医学生物学研究所

• Tobinai Kensei

  National Cancer Center Hospital

• Tagawa Hiroyuki

  Department Of Mathematical Sciences University Of Tokyo

• Oyama Takashi

  Department Of Hematology Nagoya Daini Red Cross Hospital

• Ogura Michinori

  Department Of Hematology And Cell Therapy Aichi Cancer Center

• Ogura Michinori

  Department Of Hematology And Chemotherapy Aichi Cancer Center Hospital

• Kagami Yoshitoyo

  Department Of Pathology School Of Medicine Kurume University

• Kato Harumi

  Department Of Hematology And Cell Therapy Aichi Cancer Center Hospital

• Oshiro Aya

  Department Of Hematology And Cell Therapy Aichi Cancer Center Hospital

• Morishima Yasuo

  Department Of Hematology And Cell Therapy Aichi Cancer Center

• Kagami Yoshitoyo

  Department Of Hematology And Cell Therapy Aichi Cancer Center

• Taniguchi Hirokazu

  Clinical Laboratory Division National Cancer Center Hospital

• Oyama Takashi

  Department Of Medical Oncology Aichi Cancer Center

• Kawai Yasukazu

  Department Of Hematology Japanese Red Cross Nagoya First Hospital

• Yano Kunio

  県西部浜松医療センター

• Kato Hiroya

  Departments Of Pathology And Clinical Laboratories

• Oyama Takashi

  Department Of Hematology And Oncology Nagoya Daini Red Cross Hospital

• Morishima Yasuo

  Department Of Pathology And Oncology Institute Of Medical Science University Of Tokyo

• Ogura Michinori

  Department Of Hematology And Chemotherapy Aichi Cancer Center

• Kimura Yoshizo

  Department Of Pathology School Of Medicine Kurume University

• Nakamura Satoko

  Department Of Pathology Okayama University Graduate School Of Medicine Dentistry And Pharmaceutical

• Nakamura Shigeo

  Department Of Cardiovascular Diseases. Kokura National Hospital

• NAKAMURA Shigeo

  Department of Applied Chemistry, Faculty of Engineering, Kanagawa University

関連論文

• ゲノム情報を生かした個別化医療 (特集 固形癌の最新治療--癌治療への新たな取り組み) -- (治療の新たな取り組み 個別化治療)
• Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia : results of the JALSG AML97 study
• Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia : the JALSG AML95 study
• Comparative analysis of remission induction therapy for high-risk MDS and AML progressed from MDS in the MDS200 study of Japan Adult Leukemia Study Group
• The Authors Reply: Sleep Complaints in Hospitalized Italian Patients with Hematological Malignancies
• Insomnia and Depression during Protective Isolation in Patients with Hematological Disorders
• P-674 大腸癌肝転移切除例のSurgical Marginについての遺伝子学的および組織学的検討
• PP-1137 大腸癌肝転移に対する外科的治療戦略 : Surgical Marginについての遺伝子学的および臨床病理学的検討
• SF-107-4 大腸sm癌のリンパ節転移と遺伝子群のマイクロアレイによる解析(第107回日本外科学会定期学術集会)
• 大腸の増殖形式(PG・NPG)と遺伝子群のマイクロアレイによる解析,悪性度についての検討
• マイクロアレイによる大腸癌の異時性肝転移の高リスク群の抽出
• PJ-478 The Detection of Cancer with Multidetecter Computed Tomography Coronary Angiography(PJ081,CT/MRI (Coronary/Vascular) 3 (I),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
• PJ-408 Sirolimus-eluting Stent Implantation for In-stent Restenosis of Bare Metal Stent or Sirolimus-eluting Stent(PJ069,Coronary Revascularization, PCI (Restenosis/Others) 1 (IHD),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japane
• OJ-121 Predictors of Recurrent Restenosis after Treatment of Bifurcation Lesions with the Two-stent Strategy(OJ21,Coronary Revascularization, PCI (Complex Lesions) 2 (IHD),Oral Presentation (Japanese),The 73rd Annual Scientific Meeting of The Japanese Cir
• SY-1-2-5 肝細胞癌の進展機構解析による新規分子標的の同定(シンポジウム1-2 消化器癌の発生機序から見た治療戦略-肝胆膵癌,第62回日本消化器外科学会定期学術総会)
• PS-095-1 n0乳癌における再発予後予測システムの検討
• SY-6-6 癌遺伝子発現パターンを用いたPaclitaxelの治療効果予知 : 局所進行乳癌に対する術前化療による解析
• 早期大腸癌の発育形態と Ras-signaling Pathway 異常(第105回日本外科学会定期学術集会)
• PS-117-2 散発性大腸癌発癌におけるhMLH1発現低下の意義
• Histological and immunophenotypic changes in 59 cases of B-cell non-Hodgkin's lymphoma after rituximab therapy
• Diffuse large B-cell lymphoma after transformation from low-grade follicular lymphoma : morphological, immunohistochemical, and FISH analyses
• Phase I and II pharmacokinetic and pharmacodynamic study of the proteasome inhibitor bortezomib in Japanese patients with relapsed or refractory multiple myeloma
• A-3 インベーダ法によるSNP遺伝子型データの2変量正規混合分布に基づく分類(企画セッション:SNPデータの解析における統計的諸問題)(2003年度統計関連学会連合大会記録(日本統計学会第71回大会))
• Phase II study of tacrolimus and methotrexate for prophylaxis of acute graft-versus-host disease after HLA-A, B, and DRB1 genotypically mismatched unrelated bone marrow transplantation among Japanese patients
• 発がん・増殖 BRCA遺伝子機能とその機能欠損による乳癌発生機序 (乳癌--基礎と臨床の架け橋)
• 図説 最新のゲノムワイド解析技術 (特集 ゲノム研究最前線--疾患ゲノム研究の現状と展望)
• 癌と骨転移のゲノム学 (特集 骨・破壊と再生のゲノム医学)
• 遺伝性乳癌の分子遺伝学--BRCA1を中心に (癌抑制遺伝子--最新トピックス)
• SNPsと有害事象情報 (特集 分子・細胞標的治療--基礎と臨床) -- (基礎)
• がんの遺伝解析 (特集 ポストゲノム時代の医療) -- (ゲノム解析からの病態解明)
• 大腸癌表層部と先進部の発現プロファイル解析
• IS-3-4 乳がん術前化学療法の効果予測システム開発の試み(第108回日本外科会定期学術集会)
• A Japanese patient with Li-Fraumeni syndrome who had nine primary malignancies associated with a germline mutation of the p53 tumor-suppressor gene
• SF-108-2 大腸癌先進部脱分化に関与する遺伝子群の同定と機能ネットワークの構築(第107回日本外科学会定期学術集会)
• O-109 原発性肺癌切除時の開胸時胸腔内洗浄液における微量肺癌細胞の検出と細胞診の比較(肺癌と分子生物学2, 第47回日本肺癌学会総会)
• DP-009-4 包括的遺伝子発現解析による膵癌リンパ節転移予測マーカーの同定(第108回日本外科学会定期学術集会)
• Outcome of allogeneic bone marrow transplantation from unrelated donors for adult Philadelphia chromosome-negative acute lymphocytic leukemia in first complete-remission
• Linkage of expression of chemokine receptors (CXCR3 and CCR4) and cytotoxic molecules in peripheral T cell lymphoma, not otherwise specified and ALK-negative anaplastic large cell lymphoma
• Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan
• PJ-408 Sirolimus-eluting Stent Implantation for In-stent Restenosis of Bare Metal Stent or Sirolimus-eluting Stent(PJ069,Coronary Revascularization, PCI (Restenosis/Others) 1 (IHD),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japane
• OJ-121 Predictors of Recurrent Restenosis after Treatment of Bifurcation Lesions with the Two-stent Strategy(OJ21,Coronary Revascularization, PCI (Complex Lesions) 2 (IHD),Oral Presentation (Japanese),The 73rd Annual Scientific Meeting of The Japanese Cir
• Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size : a report by the Nagasaki CML Study Group
• Cross-sectional analysis of germline BRCA1 and BRCA2 mutations in Japanese patients suspected to have hereditary breast/ovarian cancer
• Management of infection in patients with acute leukemia during chemotherapy in Japan : questionnaire analysis by the Japan Adult Leukemia Study Group
• A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL
• PJ-408 Sirolimus-eluting Stent Implantation for In-stent Restenosis of Bare Metal Stent or Sirolimus-eluting Stent(PJ069,Coronary Revascularization, PCI (Restenosis/Others) 1 (IHD),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japane
• OJ-121 Predictors of Recurrent Restenosis after Treatment of Bifurcation Lesions with the Two-stent Strategy(OJ21,Coronary Revascularization, PCI (Complex Lesions) 2 (IHD),Oral Presentation (Japanese),The 73rd Annual Scientific Meeting of The Japanese Cir
• PJ-408 Sirolimus-eluting Stent Implantation for In-stent Restenosis of Bare Metal Stent or Sirolimus-eluting Stent(PJ069,Coronary Revascularization, PCI (Restenosis/Others) 1 (IHD),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japane
• OJ-121 Predictors of Recurrent Restenosis after Treatment of Bifurcation Lesions with the Two-stent Strategy(OJ21,Coronary Revascularization, PCI (Complex Lesions) 2 (IHD),Oral Presentation (Japanese),The 73rd Annual Scientific Meeting of The Japanese Cir
• PJ-408 Sirolimus-eluting Stent Implantation for In-stent Restenosis of Bare Metal Stent or Sirolimus-eluting Stent(PJ069,Coronary Revascularization, PCI (Restenosis/Others) 1 (IHD),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japane
• OJ-121 Predictors of Recurrent Restenosis after Treatment of Bifurcation Lesions with the Two-stent Strategy(OJ21,Coronary Revascularization, PCI (Complex Lesions) 2 (IHD),Oral Presentation (Japanese),The 73rd Annual Scientific Meeting of The Japanese Cir
• P-7 原発性肺癌切除時の開胸時胸腔内洗浄液におけるCEA-mRNAの検出の意義(一般演題(ポスター) トランスレーショナルリサーチ,第48回日本肺癌学会総会)
• Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
• Japanese phase II study of ^Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma
• Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia : results of a prospective study in Japan
• Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study
• Hematopoietic stem cell transplantation for acute promyelocytic leukemia in second or third complete remission : a retrospective analysis in the Nagoya Blood and Marrow Transplantation Group
• Diagnosis of acute myeloid leukemia according to the WHO classification in the Japan Adult Leukemia Study Group AML-97 protocol
• 乳がんのLarge-scale genomic study
• Monosomies 7p and 12p and FLT3 internal tandem duplication : possible markers for diagnosis of T/myeloid biphenotypic acute leukemia and its clonal evolution
• Allelic Losses of Loci at 3p25.1,8p22,13q12,17p13.3,and 22q13 Correlate with Postoperative Recurrence in Breast Cancer
• Successful cord blood transplantation for mycosis fungoides.
• Phase II study of a salvage regimen using cyclophosphamide, high-dose cytarabine, dexamethasone, etoposide, and rituximab in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma
• Primary Hepatic Follicular Lymphoma : A Case Report and Discussion of Chemotherapy and Favorable Outcomes
• CD56/NCAM-Positive Langerhans Cell Sarcoma : A Clinicopathologic Study of 4 Cases
• HNPCC患者の放射線治療の安全性に関する検討(第105回日本外科学会定期学術集会)
• Histological Features of Breast Cancer, Highly Sensitive to Chemotherapy
• Identifying haplotype block structure using an ancestor-derived model
• Increased incidence of interstitial pneumonia by CHOP combined with rituximab
• Impaired TCR signaling through dysfunction of lipid rafts in sphingomyelin synthase 1 (SMS1)-knockdown T cells
• Safety and efficacy of rasburicase (SR29142) in a Japanese phase II study
• Allelic Loss at 1p34,13q12,17p13.3,and 17q21.1 Correlates With Poor Postoperative Prognosis in Breast Cancer
• Correlation of Allelic Loss with Poor Postoperative Survival in Breast Cancer
• Frequent Allelic Loss at 6q26-27 in Breast Carcinomas of the Solid-tubular Histologic Type
• Correlation of Allelic Losses and Clinicopathological Factors in Primary Breast Cancers
• Mapping of a Breast Cancer Tumor Suppressor Gene Locus to a 4-cM Interval on Chromosome 18q21
• Clinicopathological Features of Hereditary Breast Cancer
• Expression profiling to predict postoperative prognosis for estrogen receptor-negative breast cancers by analysis of 25,344 genes on a cDNA microarray
• Tocilizumab is effective for pulmonary hypertension associated with multicentric Castleman's disease
• Identification of Rad51 alteration in patients with bilateral breast cancer
• High proportion of missense mutations of the BRCA1 and BRCA2 genes in Japanese breast cancer families
• Multiplex Mutation Screening of the BRCA1 Gene in 1000 Japanese Breast Cancers
• Infrequent Mutation of the H-Cadherin Gene on Chromosome 16q24 in Human Breast Cancers
• Circulating tumor cells as a surrogate marker for determining response to chemotherapy in patients with advanced gastric cancer
• Bilateral Nonpalpable Breast Carcinomas in a Patient with BRCA2 Germ Line Mutation and Past History of Osteosarcoma
• Clinical features of adult acute leukemia with 11q23 abnormalities in Japan : a co-operative multicenter study
• PJ-672 Long Term Outcomes after Percutaneous Coronary Intervention(PCI) in Patient with Chronic Total Occlusion(CTO)(Coronary revascularization, PCI-22 (IHD) PJ113,Poster Session (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Ci
• PJ-524 Initial Experience of the New Tapered-tip Guide-wire in the Treatment of Chronic Total Occlusions(Coronary revascularization, PCI-19 (IHD) PJ88,Poster Session (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Soc
• PJ-421 Predictors of Recurrent Restenosis after Sirolimus-eluting Stent Implantation for In-stent Restenosis Lesions(Restenosis, basic/clinical-5 (IHD) PJ71,Poster Session (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulati
• PE-218 Long-term Follow-up of Parmacological and Ablation Therapy in Patients with Paroxysmal Atrial Fibrillation Who Develop Atrial Flutter(Arrhythmia, diagnosis/pathophysiology/EPS-9 (A) PE37,Poster Session (English),The 70th Anniversary Annual Scientif
• 癌抑制遺伝子BRCA1/2の機能およびPARP阻害剤によるBRCA変異陽性乳癌の治療 (特集 癌治療・発癌・老化の鍵を握るDNA修復経路)
• High-resolution melting analysis for a reliable and two-step scanning of mutations in the tyrosine kinase domain of the chimerical bcr-abl gene.
• Autophagy and autophagic cell death are next targets for elimination of the resistance to tyrosine kinase inhibitors
• Continuous treatment of bestatin induces anti-angiogenic property in endothelial cells
• Differential Regulation of Eotaxin-1/CCL11 and Eotaxin-3/CCL26 Production by the TNF-α and IL-4 Stimulated Human Lung Fibroblast(Pharmacology)
• Familial breast and ovarian cancers
• Analysis of extracellular matrix of a skin tumor from patients with juvenile hyaline fibromatosis
• Sentinel Lymph Node Biopsy Using Tin Colloid RI and Blue Dye Method
• Successful treatment using tacrolimus ointment for cutaneous graft-versus-host disease
• Potential efficacy of the oral histone deacetylase inhibitor vorinostat in a phase I trial in follicular and mantle cell lymphoma

もっと見る 閉じる

スポンサーリンク